Amgen Inc.

Country
USA
Краткое название
Amgen Inc.
Headquarters
One Amgen Center Drive
Members of the board

Balachandran, Madhavan — EVP, Operations
Blatter, Victoria H. — SVP, U.S. Government Affairs
Blaug, Suzanne — SVP, Global Marketing and Commercial Development
Bradway, Robert A. — Chairman and Chief Executive Officer
Eisenberg, Paul R. — SVP, Global Regulatory Affairs and Safety
Harper, Sean E. — EVP, Research and Development
Hoffmann, Rolf K. — SVP, U.S. Commercial Operations
Hooper, Anthony C. — EVP, Global Commercial Operations
Jordan, Raymond C. — SVP, Corporate Affairs
McKenzie, Diana L. — SVP and CIO
McNamee, Brian M. — SVP, Human Resources
Moore, Alison — SVP, Operations Technology
Ofman, Joshua J. — SVP, Global Value and Access
Patton, Cynthia M. — SVP and Chief Compliance Officer
Peacock, Jonathan M. — EVP and CFO
Scott, David J. — SVP — General Counsel and Secretary
Severino, Michael — SVP, Global Development and Corporate Chief Medical Officer

Categories medicine
Cardiology, Neurology, Oncology, Orthopedics
Stage of the project
Production
Disease
Arthrosis, Ischemic heart disease
Ticker
AMGN
Current owners

David Baltimore
Frank J. Biondi, Jr.
Robert A. Bradway
Francois de Carbonnel
Vance D. Coffman
Robert A. Eckert
Rebecca M. Henderson, Ph.D
Frank C. Herringer
Tyler Jacks
Gilbert S. Omenn
Judith C. Pelham
Adm. J. Paul Reason, USN (Retired)
Leonard D. Schaeffer
Ronald D. Sugar

Assets
121.5700
Technology
Cell Technologies, Homogeneous antibodies, Devices, Technologies, Pharmaceuticals, Chemistry